SCI时时刷

search
Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International L...
Teprotumumab: A Review in Thyroid Eye Disease
Teprotumumab: A Review in Thyroid Eye Disease
Teprotumumab (TEPEZZA®), a monoclonal antibody that inhibits the insulin-like growth factor 1 receptor (IGF-1R), is t...
Spesolimab: First Approval
Spesolimab: First Approval
Spesolimab (spesolimab-sbzo; SPEVIGO®) is an interleukin (IL)-36 receptor antagonist being developed by Boehringer In...
Deucravacitinib: First Approval
Deucravacitinib: First Approval
Deucravacitinib (SOTYKTU™) is a first-in-class, highly selective, oral tyrosine kinase 2 (TYK2) inhibitor. It acts v...
Valemetostat Tosilate: First Approval
Valemetostat Tosilate: First Approval
Valemetostat tosilate (valemetostat; EZHARMIA®), a selective dual inhibitor of histone-lysine N-methyltransferases en...
Correction to: Darinaparsin: First Approval
Correction to: Darinaparsin: First Approval
Abstract, second sentence, which currently reads:An intravenous formulation of darinaparsin h...
Empagliflozin: A Review in Symptomatic Chronic Heart Failure
Empagliflozin: A Review in Symptomatic Chronic Heart Failure
Empagliflozin (Jardiance®), a sodium-glucose cotransporter 2 inhibitor (SGLT2i) initially developed to treat type 2 d...
Teclistamab: First Approval
Teclistamab: First Approval
Teclistamab (TECVAYLI®), a bispecific antibody that targets CD3 and B cell maturation antigen (BCMA), is being develo...
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
Chronic kidney disease (CKD) affects approximately 10% of the worldwide population; anaemia is a frequent complication. In...
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
An oral fixed-dose combination of relugolix/estradiol/norethisterone (also known as norethindrone) acetate (Ryeqo®; M...
Darinaparsin: First Approval
Darinaparsin: First Approval
Darinaparsin (Darvias®), an organoarsenic drug, is a novel mitochondrial-targeted anticancer agent currently being de...
Pucotenlimab: First Approval
Pucotenlimab: First Approval
Pucotenlimab (Puyouheng™) is a humanised immunoglobulin (Ig) G4 monoclonal antibody (mAb) being developed by Lepu Bi...
Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy
Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy
Ripretinib (Qinlock®) is a small molecule inhibitor of the receptor tyrosine kinases KIT and platelet-derived growth ...
Lenacapavir: First Approval
Lenacapavir: First Approval
Lenacapavir (Sunlenca®) is a long-acting capsid inhibitor of human immunodeficiency virus type 1 (HIV-1) bei...
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
Due to their potent anti-inflammatory capacity (particularly in predominantly eosinophilic inflammation) and immunosuppres...
Novel Drug Therapeutics in Celiac Disease: A Pipeline Review
Novel Drug Therapeutics in Celiac Disease: A Pipeline Review
Celiac disease (CeD) is a chronic, autoimmune systemic disorder triggered by the ingestion of gluten, a protein found in f...
Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis
Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis
Cabotegravir extended-release (ER) injectable suspension (Apretude™) is the first long-acting injectable option to b...
Emerging Targeted Therapies for Early Breast Cancer
Emerging Targeted Therapies for Early Breast Cancer
Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in the United States ...
Valoctocogene Roxaparvovec: First Approval
Valoctocogene Roxaparvovec: First Approval
Valoctocogene roxaparvovec (ROCTAVIAN™) is a gene therapy being developed by BioMarin Pharmaceutical Inc. for the tr...
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease
Increasing endogenous tear film production via pharmacological neuroactivation of the nasolacrimal reflex [NLR; also known...
Cancer Pain Treatment Strategies in Patients with Cancer
Cancer Pain Treatment Strategies in Patients with Cancer
Management of cancer pain is challenging. Despite the poor evidence, opioid therapy still remains the cornerstone for the ...
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder involving loss of upper and lower ...
On the Verge of Precision Medicine in Diabetes
On the Verge of Precision Medicine in Diabetes
The epidemic of type 2 diabetes (T2D) is a significant global public health challenge and a major cause of morbidity and m...
Correction to: Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
Correction to: Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International L...